Pages that link to "Q57636788"
Jump to navigation
Jump to search
The following pages link to Roscovitine in B-chronic lymphocytic leukemia cells: high apoptosis-inducing efficacy and synergism with alemtuzumab independent of the patients' pretreatment status (Q57636788):
Displaying 7 items.
- Roscovitine in cancer and other diseases (Q26799874) (← links)
- Identification and structural-functional analysis of cyclin-dependent kinases of the cattle tick Rhipicephalus (Boophilus) microplus (Q28534360) (← links)
- Phase I and pharmacologic study of SNS-032, a potent and selective Cdk2, 7, and 9 inhibitor, in patients with advanced chronic lymphocytic leukemia and multiple myeloma (Q37163806) (← links)
- Whether to target single or multiple CDKs for therapy? That is the question (Q37788083) (← links)
- Novel potent pharmacological cyclin-dependent kinase inhibitors (Q37855812) (← links)
- Transcription inhibition as a therapeutic target for cancer (Q38161381) (← links)
- Seliciclib in malignancies (Q43235605) (← links)